119 related articles for article (PubMed ID: 6759822)
1. Unique expression of HLA-DR (Ia-like) antigen in the lesions of polar tuberculoid leprosy.
Ridley MJ; Ridley DS
Lepr Rev; 1982 Dec; 53(4):249-52. PubMed ID: 6759822
[No Abstract] [Full Text] [Related]
2. Quantitation of HLA-DR expression by cells involved in the skin lesions of tuberculoid and lepromatous leprosy.
Collings LA; Tidman N; Poulter LW
Clin Exp Immunol; 1985 Jul; 61(1):58-66. PubMed ID: 3862470
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR antigens in tuberculoid and lepromatous leprosy.
Rea TH; Terasaki PI
Lepr Rev; 1980 Jun; 51(2):117-23. PubMed ID: 6936573
[No Abstract] [Full Text] [Related]
4. The involvement of dendritic cells in the cutaneous lesions associated with tuberculoid and lepromatous leprosy.
Collings LA; Waters MF; Poulter LW
Clin Exp Immunol; 1985 Dec; 62(3):458-67. PubMed ID: 3910315
[TBL] [Abstract][Full Text] [Related]
5. HLA-linked control of predisposition to lepromatous leprosy.
van Eden W; Gonzalez NM; de Vries RR; Convit J; van Rood JJ
J Infect Dis; 1985 Jan; 151(1):9-14. PubMed ID: 3880800
[TBL] [Abstract][Full Text] [Related]
6. An immunoperoxidase study of immunological factors in high immune and low resistance granulomas in leprosy.
Ridley MJ; Russell D
J Pathol; 1982 Jun; 137(2):149-57. PubMed ID: 7045310
[TBL] [Abstract][Full Text] [Related]
7. [Expression of HLA-DR antigens (Ia-like antigens) in the cornea].
Gronemeyer U; Stein H; Gerdes J
Fortschr Ophthalmol; 1983; 80(4):345-7. PubMed ID: 6354897
[No Abstract] [Full Text] [Related]
8. Occasional review--HLA and leprosy: a re-evaluation.
van Eden W; de Vries RR
Lepr Rev; 1984 Jun; 55(2):89-104. PubMed ID: 6431213
[No Abstract] [Full Text] [Related]
9. HLA-linked control of susceptibility to tuberculoid leprosy and association with HLA-DR types.
de Vries RR; Mehra NK; Vaidya MC; Gupte MD; Meera Khan P; Van Rood JJ
Tissue Antigens; 1980 Oct; 16(4):294-304. PubMed ID: 7008255
[TBL] [Abstract][Full Text] [Related]
10. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR
Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780
[TBL] [Abstract][Full Text] [Related]
11. Associations between human leukocyte antigens and leprosy in the Turkish population.
Koçak M; Balci M; Pençe B; Kundakçi N
Clin Exp Dermatol; 2002 May; 27(3):235-9. PubMed ID: 12072016
[TBL] [Abstract][Full Text] [Related]
12. The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes.
Van Voorhis WC; Kaplan G; Sarno EN; Horwitz MA; Steinman RM; Levis WR; Nogueira N; Hair LS; Gattass CR; Arrick BA; Cohn ZA
N Engl J Med; 1982 Dec; 307(26):1593-7. PubMed ID: 6216407
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural documentation of HLA-DR antigen reactivity in normal human acrosyringial epithelium.
Murphy GF; Shepard RS; Harrist TJ; Bronstein BR; Bhan AK
J Invest Dermatol; 1983 Aug; 81(2):181-3. PubMed ID: 6348181
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the immunogenetic background of Japanese leprosy patients by the HLA system.
Izumi S; Sugiyama K; Matsumoto Y; Ohkawa S
Vox Sang; 1982; 42(5):243-7. PubMed ID: 6954762
[TBL] [Abstract][Full Text] [Related]
15. Leprosy associated with HLA-DR2 and DQw1 in the population of northern Thailand.
Schauf V; Ryan S; Scollard D; Jonasson O; Brown A; Nelson K; Smith T; Vithayasai V
Tissue Antigens; 1985 Oct; 26(4):243-7. PubMed ID: 3878012
[TBL] [Abstract][Full Text] [Related]
16. Influence of delayed immune reactions on human epidermal keratinocytes.
Kaplan G; Witmer MD; Nath I; Steinman RM; Laal S; Prasad HK; Sarno EN; Elvers U; Cohn ZA
Proc Natl Acad Sci U S A; 1986 May; 83(10):3469-73. PubMed ID: 3085090
[TBL] [Abstract][Full Text] [Related]
17. In vitro studies on the effect of levamisole in lepromatous leprosy.
Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
J Clin Lab Immunol; 1984 Feb; 13(2):93-6. PubMed ID: 6374154
[TBL] [Abstract][Full Text] [Related]
18. T cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies.
Narayanan RB; Bhutani LK; Sharma AK; Nath I
Clin Exp Immunol; 1983 Mar; 51(3):421-9. PubMed ID: 6342880
[TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility complex class II antigen (HLA-DR, DQ and DP) expression in human fetal skin.
Sewell HF; Thomson AW; Walker F; King G; Abramovich DR
Tissue Antigens; 1986 Jul; 28(1):41-5. PubMed ID: 3529495
[TBL] [Abstract][Full Text] [Related]
20. Antigen specific macrophage-lymphocyte interaction in lepromatous leprosy.
Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
J Clin Lab Immunol; 1984 Apr; 13(4):189-94. PubMed ID: 6376810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
